Earnings calendar/ARQT
Arcutis Biotherapeutics, Inc. (ARQT)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 27, 2026
Consensus estimate row
EPS target
$0.17
Street estimate
Revenue target
$141.0M
Street estimate
Trailing EPS (avg 4Q)
$0.05
Beat rate last 4: 75%
Latest EPS YoY
+184.6%
vs 2025-08-06
Latest revenue YoY
+59.3%
How results look so far
Trailing revenue (avg 4Q)
$116.0M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS beat
EPS actual / est
$0.11 / $0.06
+99.6%
Revenue actual / est
$129.9M / $118.9M
+9.3%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/27/2026upcoming | $0.17 | Pending | — | $141.0M | Pending | — |
| 8/5/2026 | $0.06 | $0.11 | +99.6% | $118.9M | $129.9M | +9.3% |
| 5/6/2026 | $-0.02 | $-0.09 | -350.0% | $103.7M | $105.4M | +1.7% |
| 5/5/2026upcoming | $-0.03 | Pending | — | $102.2M | Pending | — |
| 2/25/2026 | $0.03 | $0.13 | +333.3% | $113.1M | $129.5M | +14.5% |
| 2/24/2026upcoming | $0.02 | Pending | — | — | Pending | — |
| 10/28/2025 | $-0.10 | $0.06 | +160.0% | $110.8M | $99.2M | -10.4% |
| 8/6/2025 | $-0.18 | $-0.13 | +27.8% | $80.6M | $81.5M | +1.1% |
| 5/6/2025 | $-0.21 | $-0.20 | +4.8% | $72.7M | $65.8M | -9.4% |
| 2/25/2025 | $-0.28 | $-0.09 | +67.9% | $60.5M | $71.4M | +17.9% |
| 11/6/2024 | $-0.42 | $-0.33 | +21.4% | $37.6M | $44.8M | +19.0% |
| 8/14/2024 | $-0.48 | $-0.42 | +12.5% | $29.1M | $30.9M | +6.1% |
| 5/14/2024 | $-0.60 | $-0.32 | +46.7% | $14.7M | $49.6M | +236.3% |
| 2/27/2024 | $-0.65 | $-0.72 | -10.8% | $11.3M | $13.5M | +19.3% |
| 11/3/2023 | $-0.90 | $-0.73 | +18.9% | $11.6M | $38.1M | +229.4% |
| 8/8/2023 | $-1.22 | $-1.16 | +4.9% | $4.6M | $5.2M | +12.8% |
| 5/9/2023 | $-1.30 | $-1.31 | -0.8% | $3.1M | $2.8M | -11.4% |
| 2/28/2023 | $-1.37 | $-1.18 | +13.9% | $2.2M | $3.0M | +34.4% |
| 11/8/2022 | $-1.54 | $-1.89 | -22.7% | $614,286 | $725,000 | +18.0% |
| 8/4/2022 | $-1.38 | $-1.31 | +5.1% | — | Pending | — |
| 5/5/2022 | $-1.42 | $-1.27 | +10.6% | — | Pending | — |
| 2/22/2022 | $-1.41 | $-1.42 | -0.7% | — | Pending | — |
| 11/4/2021 | $-1.09 | $-1.14 | -4.6% | — | Pending | — |
| 8/5/2021 | $-0.91 | $-0.84 | +7.7% | — | Pending | — |
| 5/4/2021 | $-0.96 | $-0.76 | +20.8% | — | Pending | — |
| 2/16/2021 | $-0.89 | $-0.79 | +11.2% | — | Pending | — |
| 11/5/2020 | $-0.95 | $-1.01 | -6.3% | — | Pending | — |
| 8/11/2020 | $-0.84 | $-0.94 | -11.9% | — | Pending | — |
| 5/12/2020 | $-0.92 | $-1.15 | -25.0% | — | Pending | — |
| 3/19/2020 | $-9.21 | $-6.18 | +32.9% | — | Pending | — |
| 1/31/2020 | — | $-0.40 | — | — | Pending | — |
| 6/30/2019 | — | $-0.22 | — | — | Pending | — |
| 3/31/2019 | — | $-0.17 | — | — | Pending | — |
| 12/31/2018 | — | $-0.15 | — | — | Pending | — |
| 9/30/2018 | — | $-0.21 | — | — | Pending | — |
| 6/30/2018 | — | $-0.08 | — | — | Pending | — |
| 3/31/2018 | — | $-0.08 | — | — | Pending | — |